Search
Filgrastim
Filgrastim is a short-acting recombinant, non-pegylated human granulocyte colony-stimulating factor (G-CSF) analog produced by recombinant DNA technology. It has an amino acid sequence identical to endogenous G-CSF, but it is non-glycosylated unlike the endogenous G-CSF and has an N-terminal methionine added in the ...
Pegfilgrastim
go.drugbank.com/drugs/DB00019ApprovedInvestigational[A29,A187607] Due to a longer half-life and slower elimination rate than filgrastim, pegfilgrastim requires less frequent dosing than filgrastim; however, pegfilgrastim has a comparable pharmacological … [A187631] Due to the relatively short circulating half-life of filgrastim, a 20 kDa PEG moiety was covalently conjugated to the N-terminus of filgrastim (at the methionine residue) to develop longer-acting
Synonyms: peg-filgrastimMotixafortide
go.drugbank.com/drugs/DB14939ApprovedInvestigationaltwo apheresis procedures, compared to ~26% of patients receiving only filgrastim. … [L48116] When administered alongside [filgrastim], another agent used to aid in stem cell collection, motixafortide enabled the collection of an adequate number of stem cells in ~92% of patients within
Ancestim
go.drugbank.com/drugs/DB09103ApprovedWithdrawnAncestim is a non-glycosylated recombinant methionyl human stem cell factor. It is a 166 amino acid protein produced by E. coli with an amino acid sequence that is identical to the natural sequence predicted from human DNA sequence analy...
Leridistim
go.drugbank.com/drugs/DB15095InvestigationalLeridistim is under investigation in clinical trial NCT00004215 (Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia).
Polyethylene glycol 400
go.drugbank.com/drugs/DB11077ApprovedInvestigationalExamples of PEGylated medications are PEG-interferon alpha (Pegintron) and PEG-filgrastim. In addition, PEG is available as a bowel preparation for colonoscopy procedures and as a laxative [L1788].
Eflapegrastim
go.drugbank.com/drugs/DB15001ApprovedInvestigational[A252320] Granulocyte-colony stimulating factors (G-CSFs) - which include [filgrastim] and [pegfilgrastim] - were first used clinically in the 1990s and are the primary means of prophylaxis against